Compile Data Set for Download or QSAR
Found 245 Enz. Inhib. hit(s) with all data for entry = 3293
TargetTGF-beta receptor type-1 [T204D](Homo sapiens (Human))
Rigel Pharmaceuticals, Inc

US Patent
LigandPNGBDBM396701(6-(6'-chloro-[2,2'-bipyridin]-3- yl)imidazo[1,2-a]...)
Show SMILES NC(=O)c1cnc2ccc(cn12)-c1cccnc1-c1cccc(Cl)n1
Show InChI InChI=1S/C18H12ClN5O/c19-15-5-1-4-13(23-15)17-12(3-2-8-21-17)11-6-7-16-22-9-14(18(20)25)24(16)10-11/h1-10H,(H2,20,25)
Affinity DataIC50: 0.400nMAssay Description:Assays for the compounds reported below were conducted in 1536-well plates and 2 mL reactions are prepared from addition of HIS-TGFβR1 T204D or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
TargetTGF-beta receptor type-1 [T204D](Homo sapiens (Human))
Rigel Pharmaceuticals, Inc

US Patent
LigandPNGBDBM396672(6-(6'-(trifluoromethyl)-[2,2'-bipyridin]-3- yl)imi...)
Show SMILES NC(=O)c1cnc2ccc(cn12)-c1cccnc1-c1cccc(n1)C(F)(F)F
Show InChI InChI=1S/C19H12F3N5O/c20-19(21,22)15-5-1-4-13(26-15)17-12(3-2-8-24-17)11-6-7-16-25-9-14(18(23)28)27(16)10-11/h1-10H,(H2,23,28)
Affinity DataIC50: 1nMAssay Description:Assays for the compounds reported below were conducted in 1536-well plates and 2 mL reactions are prepared from addition of HIS-TGFβR1 T204D or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
TargetTGF-beta receptor type-1 [T204D](Homo sapiens (Human))
Rigel Pharmaceuticals, Inc

US Patent
LigandPNGBDBM396673(6-(5'-fluoro-6'-methyl-[2,2'-bipyridin]-3- yl)imid...)
Show SMILES Cc1nc(ccc1F)-c1ncccc1-c1ccc2ncc(C(N)=O)n2c1
Show InChI InChI=1S/C19H14FN5O/c1-11-14(20)5-6-15(24-11)18-13(3-2-8-22-18)12-4-7-17-23-9-16(19(21)26)25(17)10-12/h2-10H,1H3,(H2,21,26)
Affinity DataIC50: 1nMAssay Description:Assays for the compounds reported below were conducted in 1536-well plates and 2 mL reactions are prepared from addition of HIS-TGFβR1 T204D or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
TargetTGF-beta receptor type-1 [T204D](Homo sapiens (Human))
Rigel Pharmaceuticals, Inc

US Patent
LigandPNGBDBM396683(6-(6'-(difluoromethyl)-[2,2'-bipyridin]-3- yl)imid...)
Show SMILES NC(=O)c1cnc2ccc(cn12)-c1cccnc1-c1cccc(n1)C(F)F
Show InChI InChI=1S/C19H13F2N5O/c20-18(21)14-5-1-4-13(25-14)17-12(3-2-8-23-17)11-6-7-16-24-9-15(19(22)27)26(16)10-11/h1-10,18H,(H2,22,27)
Affinity DataIC50: 1nMAssay Description:Assays for the compounds reported below were conducted in 1536-well plates and 2 mL reactions are prepared from addition of HIS-TGFβR1 T204D or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
TargetTGF-beta receptor type-1 [T204D](Homo sapiens (Human))
Rigel Pharmaceuticals, Inc

US Patent
LigandPNGBDBM396738(6-(6'-(difluoromethyl)-5-fluoro-[2,2'-bipyridin]- ...)
Show SMILES NC(=O)c1cnc2ccc(cn12)-c1cc(F)cnc1-c1cccc(n1)C(F)F
Show InChI InChI=1S/C19H12F3N5O/c20-11-6-12(10-4-5-16-24-8-15(19(23)28)27(16)9-10)17(25-7-11)13-2-1-3-14(26-13)18(21)22/h1-9,18H,(H2,23,28)
Affinity DataIC50: 1nMAssay Description:Assays for the compounds reported below were conducted in 1536-well plates and 2 mL reactions are prepared from addition of HIS-TGFβR1 T204D or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
TargetTGF-beta receptor type-1 [T204D](Homo sapiens (Human))
Rigel Pharmaceuticals, Inc

US Patent
LigandPNGBDBM396689(6-(6'-cyclopropyl-[2,2'-bipyridin]-3- yl)imidazo[1...)
Show SMILES NC(=O)c1cnc2ccc(cn12)-c1cccnc1-c1cccc(n1)C1CC1
Show InChI InChI=1S/C21H17N5O/c22-21(27)18-11-24-19-9-8-14(12-26(18)19)15-3-2-10-23-20(15)17-5-1-4-16(25-17)13-6-7-13/h1-5,8-13H,6-7H2,(H2,22,27)
Affinity DataIC50: 1nMAssay Description:Assays for the compounds reported below were conducted in 1536-well plates and 2 mL reactions are prepared from addition of HIS-TGFβR1 T204D or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
TargetTGF-beta receptor type-1 [T204D](Homo sapiens (Human))
Rigel Pharmaceuticals, Inc

US Patent
LigandPNGBDBM396730(N-(6-(6'-methyl-[2,2'-bipyridin]-3- yl)imidazo[1,2...)
Show SMILES CC(=O)Nc1cn2cc(ccc2n1)-c1cccnc1-c1cccc(C)n1
Show InChI InChI=1S/C20H17N5O/c1-13-5-3-7-17(22-13)20-16(6-4-10-21-20)15-8-9-19-24-18(23-14(2)26)12-25(19)11-15/h3-12H,1-2H3,(H,23,26)
Affinity DataIC50: 1nMAssay Description:Assays for the compounds reported below were conducted in 1536-well plates and 2 mL reactions are prepared from addition of HIS-TGFβR1 T204D or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
TargetTGF-beta receptor type-1 [T204D](Homo sapiens (Human))
Rigel Pharmaceuticals, Inc

US Patent
LigandPNGBDBM396736(6-(5-fluoro-6'-methyl-[2,2'-bipyridin]-3- yl)imida...)
Show SMILES Cc1cccc(n1)-c1ncc(F)cc1-c1ccc2ncc(C(N)=O)n2c1
Show InChI InChI=1S/C19H14FN5O/c1-11-3-2-4-15(24-11)18-14(7-13(20)8-23-18)12-5-6-17-22-9-16(19(21)26)25(17)10-12/h2-10H,1H3,(H2,21,26)
Affinity DataIC50: 1nMAssay Description:Assays for the compounds reported below were conducted in 1536-well plates and 2 mL reactions are prepared from addition of HIS-TGFβR1 T204D or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
TargetTGF-beta receptor type-1 [T204D](Homo sapiens (Human))
Rigel Pharmaceuticals, Inc

US Patent
LigandPNGBDBM396687(6-(6'-methoxy-[2,2'-bipyridin]-3- yl)imidazo[1,2-a...)
Show SMILES COc1cccc(n1)-c1ncccc1-c1ccc2ncc(C(N)=O)n2c1
Show InChI InChI=1S/C19H15N5O2/c1-26-17-6-2-5-14(23-17)18-13(4-3-9-21-18)12-7-8-16-22-10-15(19(20)25)24(16)11-12/h2-11H,1H3,(H2,20,25)
Affinity DataIC50: 1nMAssay Description:Assays for the compounds reported below were conducted in 1536-well plates and 2 mL reactions are prepared from addition of HIS-TGFβR1 T204D or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
TargetTGF-beta receptor type-1 [T204D](Homo sapiens (Human))
Rigel Pharmaceuticals, Inc

US Patent
LigandPNGBDBM396726(US9981944, Example 72 | methyl-6-(6'-methyl-[2,2'-...)
Show SMILES CNC(=O)c1cnc2ccc(cn12)-c1cccnc1-c1cccc(C)n1
Show InChI InChI=1S/C20H17N5O/c1-13-5-3-7-16(24-13)19-15(6-4-10-22-19)14-8-9-18-23-11-17(20(26)21-2)25(18)12-14/h3-12H,1-2H3,(H,21,26)
Affinity DataIC50: 2nMAssay Description:Assays for the compounds reported below were conducted in 1536-well plates and 2 mL reactions are prepared from addition of HIS-TGFβR1 T204D or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
TargetTGF-beta receptor type-1 [T204D](Homo sapiens (Human))
Rigel Pharmaceuticals, Inc

US Patent
LigandPNGBDBM396740(6-(5,5'-difluoro-6'-methyl-[2,2'-bipyridin]-3- yl)...)
Show SMILES Cc1nc(ccc1F)-c1ncc(F)cc1-c1ccc2ncc(C(N)=O)n2c1
Show InChI InChI=1S/C19H13F2N5O/c1-10-14(21)3-4-15(25-10)18-13(6-12(20)7-24-18)11-2-5-17-23-8-16(19(22)27)26(17)9-11/h2-9H,1H3,(H2,22,27)
Affinity DataIC50: 2nMAssay Description:Assays for the compounds reported below were conducted in 1536-well plates and 2 mL reactions are prepared from addition of HIS-TGFβR1 T204D or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
TargetTGF-beta receptor type-1 [T204D](Homo sapiens (Human))
Rigel Pharmaceuticals, Inc

US Patent
LigandPNGBDBM396753(6-(5-amino-6'-methyl-[2,2'-bipyridin]-3- yl)imidaz...)
Show SMILES Cc1cccc(n1)-c1ncc(N)cc1-c1ccc2ncc(C(N)=O)n2c1
Show InChI InChI=1S/C19H16N6O/c1-11-3-2-4-15(24-11)18-14(7-13(20)8-23-18)12-5-6-17-22-9-16(19(21)26)25(17)10-12/h2-10H,20H2,1H3,(H2,21,26)
Affinity DataIC50: 2nMAssay Description:Assays for the compounds reported below were conducted in 1536-well plates and 2 mL reactions are prepared from addition of HIS-TGFβR1 T204D or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
TargetTGF-beta receptor type-1 [T204D](Homo sapiens (Human))
Rigel Pharmaceuticals, Inc

US Patent
LigandPNGBDBM396772(5-(5'-fluoro-6'-methyl-[2,2'-bipyridin]-3- yl)-1H-...)
Show SMILES Cc1nc(ccc1F)-c1ncccc1-c1ccc2[nH]ncc2c1
Show InChI InChI=1S/C18H13FN4/c1-11-15(19)5-7-17(22-11)18-14(3-2-8-20-18)12-4-6-16-13(9-12)10-21-23-16/h2-10H,1H3,(H,21,23)
Affinity DataIC50: 2nMAssay Description:Assays for the compounds reported below were conducted in 1536-well plates and 2 mL reactions are prepared from addition of HIS-TGFβR1 T204D or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
TargetTGF-beta receptor type-1 [T204D](Homo sapiens (Human))
Rigel Pharmaceuticals, Inc

US Patent
LigandPNGBDBM396765(6-(5'-fluoro-6'-methyl-[2,2'-bipyridin]-3- yl)imid...)
Show SMILES Cc1nc(ccc1F)-c1ncccc1-c1ccc2ncnc(N)c2c1
Show InChI InChI=1S/C19H14FN5/c1-11-15(20)5-7-17(25-11)18-13(3-2-8-22-18)12-4-6-16-14(9-12)19(21)24-10-23-16/h2-10H,1H3,(H2,21,23,24)
Affinity DataIC50: 2nMAssay Description:Assays for the compounds reported below were conducted in 1536-well plates and 2 mL reactions are prepared from addition of HIS-TGFβR1 T204D or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
TargetTGF-beta receptor type-1 [T204D](Homo sapiens (Human))
Rigel Pharmaceuticals, Inc

US Patent
LigandPNGBDBM396766(6-(6'-isopropyl-[2,2'-bipyridin]-3- yl)quinazolin-...)
Show SMILES Nc1ncnc2ccc(cc12)-c1cccnc1-c1cccc(n1)C1CC1
Show InChI InChI=1S/C21H17N5/c22-21-16-11-14(8-9-18(16)24-12-25-21)15-3-2-10-23-20(15)19-5-1-4-17(26-19)13-6-7-13/h1-5,8-13H,6-7H2,(H2,22,24,25)
Affinity DataIC50: 2nMAssay Description:Assays for the compounds reported below were conducted in 1536-well plates and 2 mL reactions are prepared from addition of HIS-TGFβR1 T204D or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
TargetTGF-beta receptor type-1 [T204D](Homo sapiens (Human))
Rigel Pharmaceuticals, Inc

US Patent
LigandPNGBDBM396764(6-(6'-(difluoromethyl)-[2,2'-bipyridin]-3- yl)quin...)
Show SMILES Nc1ncnc2ccc(cc12)-c1cccnc1-c1cccc(n1)C(F)F
Show InChI InChI=1S/C19H13F2N5/c20-18(21)16-5-1-4-15(26-16)17-12(3-2-8-23-17)11-6-7-14-13(9-11)19(22)25-10-24-14/h1-10,18H,(H2,22,24,25)
Affinity DataIC50: 2nMAssay Description:Assays for the compounds reported below were conducted in 1536-well plates and 2 mL reactions are prepared from addition of HIS-TGFβR1 T204D or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
TargetTGF-beta receptor type-1 [T204D](Homo sapiens (Human))
Rigel Pharmaceuticals, Inc

US Patent
LigandPNGBDBM396702(6-(6'-methyl-[2,2'-bipyridin]-3- yl)imidazo[1,2-a]...)
Show SMILES Cc1cccc(n1)-c1ncccc1-c1ccc2nccn2c1
Show InChI InChI=1S/C18H14N4/c1-13-4-2-6-16(21-13)18-15(5-3-9-20-18)14-7-8-17-19-10-11-22(17)12-14/h2-12H,1H3
Affinity DataIC50: 3nMAssay Description:Assays for the compounds reported below were conducted in 1536-well plates and 2 mL reactions are prepared from addition of HIS-TGFβR1 T204D or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
TargetTGF-beta receptor type-1 [T204D](Homo sapiens (Human))
Rigel Pharmaceuticals, Inc

US Patent
LigandPNGBDBM396770(5-(6'-(difluoromethyl)-[2,2'-bipyridin]-3- yl)-1H-...)
Show SMILES FC(F)c1cccc(n1)-c1ncccc1-c1ccc2[nH]ncc2c1
Show InChI InChI=1S/C18H12F2N4/c19-18(20)16-5-1-4-15(23-16)17-13(3-2-8-21-17)11-6-7-14-12(9-11)10-22-24-14/h1-10,18H,(H,22,24)
Affinity DataIC50: 3nMAssay Description:Assays for the compounds reported below were conducted in 1536-well plates and 2 mL reactions are prepared from addition of HIS-TGFβR1 T204D or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
TargetTGF-beta receptor type-1 [T204D](Homo sapiens (Human))
Rigel Pharmaceuticals, Inc

US Patent
LigandPNGBDBM396760(6-(6'-(difluoromethyl)-[2,2'-bipyridin]-3- yl)pyri...)
Show SMILES Nc1ncnc2ccc(nc12)-c1cccnc1-c1cccc(n1)C(F)F
Show InChI InChI=1S/C18H12F2N6/c19-17(20)14-5-1-4-13(25-14)15-10(3-2-8-22-15)11-6-7-12-16(26-11)18(21)24-9-23-12/h1-9,17H,(H2,21,23,24)
Affinity DataIC50: 3nMAssay Description:Assays for the compounds reported below were conducted in 1536-well plates and 2 mL reactions are prepared from addition of HIS-TGFβR1 T204D or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
TargetTGF-beta receptor type-1 [T204D](Homo sapiens (Human))
Rigel Pharmaceuticals, Inc

US Patent
LigandPNGBDBM396692(6-(6'-fluoro-[2,2'-bipyridin]-3- yl)imidazo[1,2-a]...)
Show SMILES NC(=O)c1cnc2ccc(cn12)-c1cccnc1-c1cccc(F)n1
Show InChI InChI=1S/C18H12FN5O/c19-15-5-1-4-13(23-15)17-12(3-2-8-21-17)11-6-7-16-22-9-14(18(20)25)24(16)10-11/h1-10H,(H2,20,25)
Affinity DataIC50: 4nMAssay Description:Assays for the compounds reported below were conducted in 1536-well plates and 2 mL reactions are prepared from addition of HIS-TGFβR1 T204D or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
TargetTGF-beta receptor type-1 [T204D](Homo sapiens (Human))
Rigel Pharmaceuticals, Inc

US Patent
LigandPNGBDBM396722(6-(6'-methyl-[2,2'-bipyridin]-3- yl)imidazo[1,2-a]...)
Show SMILES Cc1cccc(n1)-c1ncccc1-c1ccc2ncc(C(O)=O)n2c1
Show InChI InChI=1S/C19H14N4O2/c1-12-4-2-6-15(22-12)18-14(5-3-9-20-18)13-7-8-17-21-10-16(19(24)25)23(17)11-13/h2-11H,1H3,(H,24,25)
Affinity DataIC50: 4nMAssay Description:Assays for the compounds reported below were conducted in 1536-well plates and 2 mL reactions are prepared from addition of HIS-TGFβR1 T204D or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
TargetTGF-beta receptor type-1 [T204D](Homo sapiens (Human))
Rigel Pharmaceuticals, Inc

US Patent
LigandPNGBDBM396723(N-(2,2-difluoroethyl)-6-(6'-methyl-[2,2'- bipyridi...)
Show SMILES Cc1cccc(n1)-c1ncccc1-c1ccc2ncc(C(=O)NCC(F)F)n2c1
Show InChI InChI=1S/C21H17F2N5O/c1-13-4-2-6-16(27-13)20-15(5-3-9-24-20)14-7-8-19-25-10-17(28(19)12-14)21(29)26-11-18(22)23/h2-10,12,18H,11H2,1H3,(H,26,29)
Affinity DataIC50: 4nMAssay Description:Assays for the compounds reported below were conducted in 1536-well plates and 2 mL reactions are prepared from addition of HIS-TGFβR1 T204D or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
TargetTGF-beta receptor type-1 [T204D](Homo sapiens (Human))
Rigel Pharmaceuticals, Inc

US Patent
LigandPNGBDBM396761(6-(6'-cyclopropyl-[2,2'-bipyridin]-3- yl)pyrido[3,...)
Show SMILES Nc1ncnc2ccc(nc12)-c1cccnc1-c1cccc(n1)C1CC1
Show InChI InChI=1S/C20H16N6/c21-20-19-16(23-11-24-20)9-8-15(26-19)13-3-2-10-22-18(13)17-5-1-4-14(25-17)12-6-7-12/h1-5,8-12H,6-7H2,(H2,21,23,24)
Affinity DataIC50: 4nMAssay Description:Assays for the compounds reported below were conducted in 1536-well plates and 2 mL reactions are prepared from addition of HIS-TGFβR1 T204D or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
TargetTGF-beta receptor type-1 [T204D](Homo sapiens (Human))
Rigel Pharmaceuticals, Inc

US Patent
LigandPNGBDBM396731(N-(6-(5'-fluoro-6'-methyl-[2,2'-bipyridin]-3- yl)i...)
Show SMILES CC(=O)Nc1cn2cc(ccc2n1)-c1cccnc1-c1ccc(F)c(C)n1
Show InChI InChI=1S/C20H16FN5O/c1-12-16(21)6-7-17(23-12)20-15(4-3-9-22-20)14-5-8-19-25-18(24-13(2)27)11-26(19)10-14/h3-11H,1-2H3,(H,24,27)
Affinity DataIC50: 4nMAssay Description:Assays for the compounds reported below were conducted in 1536-well plates and 2 mL reactions are prepared from addition of HIS-TGFβR1 T204D or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
TargetTGF-beta receptor type-1 [T204D](Homo sapiens (Human))
Rigel Pharmaceuticals, Inc

US Patent
LigandPNGBDBM396754(6-(5-amino-6'-methyl-[2,2'-bipyridin]-3- yl)imidaz...)
Show SMILES Cc1cccc(n1)-c1ncc(N)cc1-c1ccc2ncc(C(O)=O)n2c1
Show InChI InChI=1S/C19H15N5O2/c1-11-3-2-4-15(23-11)18-14(7-13(20)8-22-18)12-5-6-17-21-9-16(19(25)26)24(17)10-12/h2-10H,20H2,1H3,(H,25,26)
Affinity DataIC50: 4nMAssay Description:Assays for the compounds reported below were conducted in 1536-well plates and 2 mL reactions are prepared from addition of HIS-TGFβR1 T204D or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
TargetTGF-beta receptor type-1 [T204D](Homo sapiens (Human))
Rigel Pharmaceuticals, Inc

US Patent
LigandPNGBDBM396758(6-(5'-fluoro-6'-methyl-[2,2'-bipyridin]-3- yl)pyri...)
Show SMILES Cc1nc(ccc1F)-c1ncccc1-c1ccc2ncnc(N)c2n1
Show InChI InChI=1S/C18H13FN6/c1-10-12(19)4-5-15(24-10)16-11(3-2-8-21-16)13-6-7-14-17(25-13)18(20)23-9-22-14/h2-9H,1H3,(H2,20,22,23)
Affinity DataIC50: 4nMAssay Description:Assays for the compounds reported below were conducted in 1536-well plates and 2 mL reactions are prepared from addition of HIS-TGFβR1 T204D or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
TargetTGF-beta receptor type-1 [T204D](Homo sapiens (Human))
Rigel Pharmaceuticals, Inc

US Patent
LigandPNGBDBM396725(N-(2-methoxyethyl)-6-(6'-methyl-[2,2'-bipyridin]- ...)
Show SMILES COCCNC(=O)c1cnc2ccc(cn12)-c1cccnc1-c1cccc(C)n1
Show InChI InChI=1S/C22H21N5O2/c1-15-5-3-7-18(26-15)21-17(6-4-10-23-21)16-8-9-20-25-13-19(27(20)14-16)22(28)24-11-12-29-2/h3-10,13-14H,11-12H2,1-2H3,(H,24,28)
Affinity DataIC50: 4nMAssay Description:Assays for the compounds reported below were conducted in 1536-well plates and 2 mL reactions are prepared from addition of HIS-TGFβR1 T204D or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
TargetTGF-beta receptor type-1 [T204D](Homo sapiens (Human))
Rigel Pharmaceuticals, Inc

US Patent
LigandPNGBDBM396793(5-(6'-methyl-[2,2'-bipyridin]-3- yl)pyrazolo[1,5-a...)
Show SMILES Cc1cccc(n1)-c1ncccc1-c1ccn2nccc2n1
Show InChI InChI=1S/C17H13N5/c1-12-4-2-6-15(20-12)17-13(5-3-9-18-17)14-8-11-22-16(21-14)7-10-19-22/h2-11H,1H3
Affinity DataIC50: 5nMAssay Description:Assays for the compounds reported below were conducted in 1536-well plates and 2 mL reactions are prepared from addition of HIS-TGFβR1 T204D or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
TargetTGF-beta receptor type-1 [T204D](Homo sapiens (Human))
Rigel Pharmaceuticals, Inc

US Patent
LigandPNGBDBM396675(6-(5'-fluoro-[2,2'-bipyridin]-3- yl)imidazo[1,2-a]...)
Show SMILES NC(=O)c1cnc2ccc(cn12)-c1cccnc1-c1ccc(F)cn1
Show InChI InChI=1S/C18H12FN5O/c19-12-4-5-14(22-8-12)17-13(2-1-7-21-17)11-3-6-16-23-9-15(18(20)25)24(16)10-11/h1-10H,(H2,20,25)
Affinity DataIC50: 5nMAssay Description:Assays for the compounds reported below were conducted in 1536-well plates and 2 mL reactions are prepared from addition of HIS-TGFβR1 T204D or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
TargetTGF-beta receptor type-1 [T204D](Homo sapiens (Human))
Rigel Pharmaceuticals, Inc

US Patent
LigandPNGBDBM396756(6-(4-amino-6'-methyl-[2,2'-bipyridin]-3- yl)imidaz...)
Show SMILES Cc1cccc(n1)-c1nccc(N)c1-c1ccc2ncc(C(N)=O)n2c1
Show InChI InChI=1S/C19H16N6O/c1-11-3-2-4-14(24-11)18-17(13(20)7-8-22-18)12-5-6-16-23-9-15(19(21)26)25(16)10-12/h2-10H,1H3,(H2,20,22)(H2,21,26)
Affinity DataIC50: 5nMAssay Description:Assays for the compounds reported below were conducted in 1536-well plates and 2 mL reactions are prepared from addition of HIS-TGFβR1 T204D or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
TargetTGF-beta receptor type-1 [T204D](Homo sapiens (Human))
Rigel Pharmaceuticals, Inc

US Patent
LigandPNGBDBM396752(6-(5-acetamido-6'-methyl-[2,2'-bipyridin]-3- yl)im...)
Show SMILES CC(=O)Nc1cnc(-c2cccc(C)n2)c(c1)-c1ccc2ncc(C(N)=O)n2c1
Show InChI InChI=1S/C21H18N6O2/c1-12-4-3-5-17(25-12)20-16(8-15(9-24-20)26-13(2)28)14-6-7-19-23-10-18(21(22)29)27(19)11-14/h3-11H,1-2H3,(H2,22,29)(H,26,28)
Affinity DataIC50: 5nMAssay Description:Assays for the compounds reported below were conducted in 1536-well plates and 2 mL reactions are prepared from addition of HIS-TGFβR1 T204D or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
TargetTGF-beta receptor type-1 [T204D](Homo sapiens (Human))
Rigel Pharmaceuticals, Inc

US Patent
LigandPNGBDBM396676(6-(4'-fluoro-[2,2'-bipyridin]-3- yl)imidazo[1,2-a]...)
Show SMILES NC(=O)c1cnc2ccc(cn12)-c1cccnc1-c1cc(F)ccn1
Show InChI InChI=1S/C18H12FN5O/c19-12-5-7-21-14(8-12)17-13(2-1-6-22-17)11-3-4-16-23-9-15(18(20)25)24(16)10-11/h1-10H,(H2,20,25)
Affinity DataIC50: 5nMAssay Description:Assays for the compounds reported below were conducted in 1536-well plates and 2 mL reactions are prepared from addition of HIS-TGFβR1 T204D or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
TargetTGF-beta receptor type-1 [T204D](Homo sapiens (Human))
Rigel Pharmaceuticals, Inc

US Patent
LigandPNGBDBM396694(6-([2,2'-bipyridin]-3- yl)imidazo[1,2-a]pyridine-3...)
Show SMILES NC(=O)c1cnc2ccc(cn12)-c1cccnc1-c1ccccn1
Show InChI InChI=1S/C18H13N5O/c19-18(24)15-10-22-16-7-6-12(11-23(15)16)13-4-3-9-21-17(13)14-5-1-2-8-20-14/h1-11H,(H2,19,24)
Affinity DataIC50: 6nMAssay Description:Assays for the compounds reported below were conducted in 1536-well plates and 2 mL reactions are prepared from addition of HIS-TGFβR1 T204D or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
TargetTGF-beta receptor type-1 [T204D](Homo sapiens (Human))
Rigel Pharmaceuticals, Inc

US Patent
LigandPNGBDBM396775(5-(6'-methyl-[2,2'-bipyridin]-3- yl)pyrazolo[1,5-a...)
Show SMILES Cc1cccc(n1)-c1ncccc1-c1ccn2ncc(C(N)=O)c2n1
Show InChI InChI=1S/C18H14N6O/c1-11-4-2-6-15(22-11)16-12(5-3-8-20-16)14-7-9-24-18(23-14)13(10-21-24)17(19)25/h2-10H,1H3,(H2,19,25)
Affinity DataIC50: 6nMAssay Description:Assays for the compounds reported below were conducted in 1536-well plates and 2 mL reactions are prepared from addition of HIS-TGFβR1 T204D or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
TargetTGF-beta receptor type-1 [T204D](Homo sapiens (Human))
Rigel Pharmaceuticals, Inc

US Patent
LigandPNGBDBM396724(6-(6'-methyl-[2,2'-bipyridin]-3-yl)-N- (2,2,2-trif...)
Show SMILES Cc1cccc(n1)-c1ncccc1-c1ccc2ncc(C(=O)NCC(F)(F)F)n2c1
Show InChI InChI=1S/C21H16F3N5O/c1-13-4-2-6-16(28-13)19-15(5-3-9-25-19)14-7-8-18-26-10-17(29(18)11-14)20(30)27-12-21(22,23)24/h2-11H,12H2,1H3,(H,27,30)
Affinity DataIC50: 7nMAssay Description:Assays for the compounds reported below were conducted in 1536-well plates and 2 mL reactions are prepared from addition of HIS-TGFβR1 T204D or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
TargetTGF-beta receptor type-1 [T204D](Homo sapiens (Human))
Rigel Pharmaceuticals, Inc

US Patent
LigandPNGBDBM396792(5-(5'-fluoro-6'-methyl-[2,2'-bipyridin]-3- yl)pyra...)
Show SMILES Cc1nc(ccc1F)-c1ncccc1-c1ccn2nccc2n1
Show InChI InChI=1S/C17H12FN5/c1-11-13(18)4-5-15(21-11)17-12(3-2-8-19-17)14-7-10-23-16(22-14)6-9-20-23/h2-10H,1H3
Affinity DataIC50: 8nMAssay Description:Assays for the compounds reported below were conducted in 1536-well plates and 2 mL reactions are prepared from addition of HIS-TGFβR1 T204D or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
TargetTGF-beta receptor type-1 [T204D](Homo sapiens (Human))
Rigel Pharmaceuticals, Inc

US Patent
LigandPNGBDBM396617(6-(6'-methoxy-[2,2'-bipyridin]-3- yl)imidazo[1,2-a...)
Show SMILES COc1cccc(n1)-c1ncccc1-c1ccc2ncc(C#N)n2c1
Show InChI InChI=1S/C19H13N5O/c1-25-18-6-2-5-16(23-18)19-15(4-3-9-21-19)13-7-8-17-22-11-14(10-20)24(17)12-13/h2-9,11-12H,1H3
Affinity DataIC50: 9nMAssay Description:Assays for the compounds reported below were conducted in 1536-well plates and 2 mL reactions are prepared from addition of HIS-TGFβR1 T204D or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
TargetTGF-beta receptor type-1 [T204D](Homo sapiens (Human))
Rigel Pharmaceuticals, Inc

US Patent
LigandPNGBDBM396768(6-(6'-methyl-[2,2'-bipyridin]-3-yl)quinoxaline | U...)
Show SMILES Cc1cccc(n1)-c1ncccc1-c1ccc2nccnc2c1
Show InChI InChI=1S/C19H14N4/c1-13-4-2-6-17(23-13)19-15(5-3-9-22-19)14-7-8-16-18(12-14)21-11-10-20-16/h2-12H,1H3
Affinity DataIC50: 9nMAssay Description:Assays for the compounds reported below were conducted in 1536-well plates and 2 mL reactions are prepared from addition of HIS-TGFβR1 T204D or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
TargetTGF-beta receptor type-1 [T204D](Homo sapiens (Human))
Rigel Pharmaceuticals, Inc

US Patent
LigandPNGBDBM396762(6-(6'-ethyl-[2,2'-bipyridin]-3-yl)quinazolin- 4-am...)
Show SMILES CCc1cccc(n1)-c1ncccc1-c1ccc2ncnc(N)c2c1
Show InChI InChI=1S/C20H17N5/c1-2-14-5-3-7-18(25-14)19-15(6-4-10-22-19)13-8-9-17-16(11-13)20(21)24-12-23-17/h3-12H,2H2,1H3,(H2,21,23,24)
Affinity DataIC50: 9nMAssay Description:Assays for the compounds reported below were conducted in 1536-well plates and 2 mL reactions are prepared from addition of HIS-TGFβR1 T204D or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
TargetTGF-beta receptor type-1 [T204D](Homo sapiens (Human))
Rigel Pharmaceuticals, Inc

US Patent
LigandPNGBDBM396682(6-(6'-(difluoromethyl)-[2,2'-bipyridin]-3- yl)imid...)
Show SMILES FC(F)c1cccc(n1)-c1ncccc1-c1ccc2ncc(C#N)n2c1
Show InChI InChI=1S/C19H11F2N5/c20-19(21)16-5-1-4-15(25-16)18-14(3-2-8-23-18)12-6-7-17-24-10-13(9-22)26(17)11-12/h1-8,10-11,19H
Affinity DataIC50: 9nMAssay Description:Assays for the compounds reported below were conducted in 1536-well plates and 2 mL reactions are prepared from addition of HIS-TGFβR1 T204D or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
TargetTGF-beta receptor type-1 [T204D](Homo sapiens (Human))
Rigel Pharmaceuticals, Inc

US Patent
LigandPNGBDBM396559(6-(5'-fluoro-6'-methyl-[2,2'-bipyridin]-3- yl)imid...)
Show SMILES Cc1nc(ccc1F)-c1ncccc1-c1ccc2ncc(C#N)n2c1
Show InChI InChI=1S/C19H12FN5/c1-12-16(20)5-6-17(24-12)19-15(3-2-8-22-19)13-4-7-18-23-10-14(9-21)25(18)11-13/h2-8,10-11H,1H3
Affinity DataIC50: 10nMAssay Description:Assays for the compounds reported below were conducted in 1536-well plates and 2 mL reactions are prepared from addition of HIS-TGFβR1 T204D or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
TargetTGF-beta receptor type-1 [T204D](Homo sapiens (Human))
Rigel Pharmaceuticals, Inc

US Patent
LigandPNGBDBM396404(6-(6'-(trifluoromethyl)-[2,2'-bipyridin]-3- yl)imi...)
Show SMILES FC(F)(F)c1cccc(n1)-c1ncccc1-c1ccc2ncc(C#N)n2c1
Show InChI InChI=1S/C19H10F3N5/c20-19(21,22)16-5-1-4-15(26-16)18-14(3-2-8-24-18)12-6-7-17-25-10-13(9-23)27(17)11-12/h1-8,10-11H
Affinity DataIC50: 11nMAssay Description:Assays for the compounds reported below were conducted in 1536-well plates and 2 mL reactions are prepared from addition of HIS-TGFβR1 T204D or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
TargetTGF-beta receptor type-1 [T204D](Homo sapiens (Human))
Rigel Pharmaceuticals, Inc

US Patent
LigandPNGBDBM396767(6-(5'-fluoro-6'-methyl-[2,2'-bipyridin]-3- yl)quin...)
Show SMILES Cc1nc(ccc1F)-c1ncccc1-c1ccc2nccnc2c1
Show InChI InChI=1S/C19H13FN4/c1-12-15(20)5-7-17(24-12)19-14(3-2-8-23-19)13-4-6-16-18(11-13)22-10-9-21-16/h2-11H,1H3
Affinity DataIC50: 12nMAssay Description:Assays for the compounds reported below were conducted in 1536-well plates and 2 mL reactions are prepared from addition of HIS-TGFβR1 T204D or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
TargetTGF-beta receptor type-1 [T204D](Homo sapiens (Human))
Rigel Pharmaceuticals, Inc

US Patent
LigandPNGBDBM396743(6-(6'-(difluoromethyl)-6-methyl-[2,2'-bipyridin]- ...)
Show SMILES Cc1ccc(-c2ccc3ncc(C(N)=O)n3c2)c(n1)-c1cccc(n1)C(F)F
Show InChI InChI=1S/C20H15F2N5O/c1-11-5-7-13(18(25-11)14-3-2-4-15(26-14)19(21)22)12-6-8-17-24-9-16(20(23)28)27(17)10-12/h2-10,19H,1H3,(H2,23,28)
Affinity DataIC50: 13nMAssay Description:Assays for the compounds reported below were conducted in 1536-well plates and 2 mL reactions are prepared from addition of HIS-TGFβR1 T204D or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
TargetTGF-beta receptor type-1 [T204D](Homo sapiens (Human))
Rigel Pharmaceuticals, Inc

US Patent
LigandPNGBDBM396771(5-(5'-fluoro-[2,2'-bipyridin]-3-yl)-1H-indazole | ...)
Show SMILES Fc1ccc(nc1)-c1ncccc1-c1ccc2[nH]ncc2c1
Show InChI InChI=1S/C17H11FN4/c18-13-4-6-16(20-10-13)17-14(2-1-7-19-17)11-3-5-15-12(8-11)9-21-22-15/h1-10H,(H,21,22)
Affinity DataIC50: 14nMAssay Description:Assays for the compounds reported below were conducted in 1536-well plates and 2 mL reactions are prepared from addition of HIS-TGFβR1 T204D or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
TargetTGF-beta receptor type-1 [T204D](Homo sapiens (Human))
Rigel Pharmaceuticals, Inc

US Patent
LigandPNGBDBM396785(US9981944, Example 130 | ethyl 5-(5'-fluoro-6'-met...)
Show SMILES CCOC(=O)c1cnn2ccc(nc12)-c1cccnc1-c1ccc(F)c(C)n1
Show InChI InChI=1S/C20H16FN5O2/c1-3-28-20(27)14-11-23-26-10-8-16(25-19(14)26)13-5-4-9-22-18(13)17-7-6-15(21)12(2)24-17/h4-11H,3H2,1-2H3
Affinity DataIC50: 14nMAssay Description:Assays for the compounds reported below were conducted in 1536-well plates and 2 mL reactions are prepared from addition of HIS-TGFβR1 T204D or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
TargetTGF-beta receptor type-1 [T204D](Homo sapiens (Human))
Rigel Pharmaceuticals, Inc

US Patent
LigandPNGBDBM396742(6-(6,6'-dimethyl-[2,2'-bipyridin]-3- yl)imidazo[1,...)
Show SMILES Cc1cccc(n1)-c1nc(C)ccc1-c1ccc2ncc(C(N)=O)n2c1
Show InChI InChI=1S/C20H17N5O/c1-12-4-3-5-16(23-12)19-15(8-6-13(2)24-19)14-7-9-18-22-10-17(20(21)26)25(18)11-14/h3-11H,1-2H3,(H2,21,26)
Affinity DataIC50: 15nMAssay Description:Assays for the compounds reported below were conducted in 1536-well plates and 2 mL reactions are prepared from addition of HIS-TGFβR1 T204D or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
TargetTGF-beta receptor type-1 [T204D](Homo sapiens (Human))
Rigel Pharmaceuticals, Inc

US Patent
LigandPNGBDBM396791(5-(6'-(trifluoromethyl)-[2,2'-bipyridin]-3- yl)pyr...)
Show SMILES FC(F)(F)c1cccc(n1)-c1ncccc1-c1ccn2nccc2n1
Show InChI InChI=1S/C17H10F3N5/c18-17(19,20)14-5-1-4-13(23-14)16-11(3-2-8-21-16)12-7-10-25-15(24-12)6-9-22-25/h1-10H
Affinity DataIC50: 15nMAssay Description:Assays for the compounds reported below were conducted in 1536-well plates and 2 mL reactions are prepared from addition of HIS-TGFβR1 T204D or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
TargetTGF-beta receptor type-1 [T204D](Homo sapiens (Human))
Rigel Pharmaceuticals, Inc

US Patent
LigandPNGBDBM396686(6-(6'-isopropyl-[2,2'-bipyridin]-3- yl)imidazo[1,2...)
Show SMILES CC(C)c1cccc(n1)-c1ncccc1-c1ccc2ncc(C(N)=O)n2c1
Show InChI InChI=1S/C21H19N5O/c1-13(2)16-6-3-7-17(25-16)20-15(5-4-10-23-20)14-8-9-19-24-11-18(21(22)27)26(19)12-14/h3-13H,1-2H3,(H2,22,27)
Affinity DataIC50: 16nMAssay Description:Assays for the compounds reported below were conducted in 1536-well plates and 2 mL reactions are prepared from addition of HIS-TGFβR1 T204D or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
TargetTGF-beta receptor type-1 [T204D](Homo sapiens (Human))
Rigel Pharmaceuticals, Inc

US Patent
LigandPNGBDBM396769(6-(6'-(trifluoromethyl)-[2,2'-bipyridin]-3- yl)qui...)
Show SMILES FC(F)(F)c1cccc(n1)-c1ncccc1-c1ccc2nccnc2c1
Show InChI InChI=1S/C19H11F3N4/c20-19(21,22)17-5-1-4-15(26-17)18-13(3-2-8-25-18)12-6-7-14-16(11-12)24-10-9-23-14/h1-11H
Affinity DataIC50: 16nMAssay Description:Assays for the compounds reported below were conducted in 1536-well plates and 2 mL reactions are prepared from addition of HIS-TGFβR1 T204D or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
Displayed 1 to 50 (of 245 total ) | Next | Last >>
Jump to: